Jump to:

NYSA TI Single-Page 1

In fact, that's an area that has received a lot

Date: No date
Length: 178 pages

Jump To Images
nysa_ti_s1 TI10111644-TI10111821

Abstract

In fact, that's an area that has received a lot of attention from the NIH, and I think people are spending more effort on interracial and ethnic differences.

Fields

Named Organization
American Cancer Society
American College of Cardiology
American Heart Association (Voluntary health organization that focuses on cardiac health)
Voluntary health organization that focuses on cardiac health and stroke. AHA occasionally teams with tobacco retailers to engage in promotions/fund-raisers (see http://www.smokefree.net/doc-alert/messages/247136.html and http://www.rawbw.com/~jpk/stand/Pictures.html).
American Journal of Public Health (periodical)
Americans for Nonsmokers' Rights (Anti tobacco organization)
Concerned with clean indoor air.
Beverly Hills Restaurant Association (Industry front group)
Set up c. 1988 by the Tobacco Institute to clandestinely fight a local smoking restriction (TI00380927-0949, Pag. -0946).
California Air Resources Board
Californians for Nonsmokers' Rights (Americans for Nonsmokers rights precursor)
Precursor organization to Americans for Nonsmokers Rights
Center for Indoor Air Research (CIAR) (Industry formed/funded air research organization)
Nonprofit organization funded by the tobacco industry. CIAR was formed in March 1988 by tobacco companies "to sponsor "high-quality research on indoor air issues and to facilitate communication of research findings to the broad scientific community."
Congressional Research Service (Criticized 1993 EPA ETS report)
Criticized EPA's January 1993 report designating passive smoke as a carcinogen
Environmental Protection Agency (EPA)
Federal Register (publication)
McDonald's Corp.
Ministry of Health and Welfare (Japan)
National Institutes of Health (NIH)
National Licensed Beverage Association
National Research Council
New England Journal of Medicine
Nonsmokers Rights (California anti-smoking organization created by Stanton Glan)
Occupational Safety and Health Administration (OSHA)
Price Waterhouse (Accounting firm)
R.J. Reynolds Corporation (second tier subsidiary of RJR Industries)
Tobacco Institute (Industry Trade Association)
The purpose of the Institute was to defeat legislation unfavorable to the industry, put a positive spin on the tobacco industry, bolster the industry's credibility with legislators and the public, and help maintain the controversy over "the primary issue" (the health issue).
*University of California (use specific branch)
University of California San Francisco
Washington Technical Information Group, Inc.
World Conference on Smoking and Health
World Health Organization (Concerned with global public health)
International organization concered with public health worldwide
Named Person
Alsop, L. Susan
Barr, Glen
Bero, Lisa A., Ph.D. (Epidemiologist, UC San Francisco)
Feinstein, Diane
Garfinkle, Larry
Glantz, Stanton
Grossman, Ted
Lee, Peter N. (TAC Biostatistician)
Frequently funded by the tobacco industry to criticize and discount published and epidemiological studies that linked between tobacco smoking and health damage.
*LeVois, Maurice (use LeVois, Maurice Emile, Ph.D.) (industry consultant)
1996 submitted comments to EPA, worked with PN Lee on IARC rebuttal.
Lowe, Michael
Mahler, Sara
Mayor, Francisco
Michaels, Robert
Parmley, Bill
Penn, Arthur
Pfeffer, William, Jr.
Rossi, Bob
Rossi, Robert
Samet, Jonathan
Siegel, Michael B., M.D. (Epidemiologist, Boston U, School of Public Health, Anti-Toba)
Toon, Michael
Wald, Nicholas J., Ph.D. (Colleague of Sir Richard Doll, coauthor with Law of secondha)
Professor of Preventive Medicine, Wolfson Institute of London, Colleague of Sir Richard Doll, coauthor with Law of secondhand smoke metaanalysis
Warner, Kenneth E., Ph.D (Plaintiff's expert, health care costs)
Plaintiff
Woods, Rosemarie
Wynder, Ernest
Master ID
TI10111465-1821

Related Documents:
Date Loaded
16 Mar 2005
Box
8820

Document Images

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size:

Page 1: TI10111644
1 2 3 4 5 6 7 8 9 I0 Ii 12 13 14 15 16 17 18 19 20 21 22 23 24 25 457 is very ligtle independent cardiovascular epidemiologyon those groups in general. In fact, that's an area that has received a lot of attention from the NIH, and I think people are spending more effort on interracial and ethnic differences. As a general rule, though, when you look at the major risk factors for heart disease, the importance of those risk factors seem to be pretty much, to my understanding, independent of ethnicity, although there are some subgroups, for example, that are more prone to hypertension, such as blacks, but the effect of the hypertension on the heart, where it doesn't seem to be different in blacks than whites. So I wouldn't see the question that you're raising as a particularly strong limitation on the studies. It would be nice if we could do the perfect study and have perfect stratification by everything imaginable, but I don't think you'll ever find a study that you can't find something to criticize. MR. SIRRIDGE: You're familiar with the migrant studies and how heart disease, risk and risk factors change from Asian -- DR. GLANTZ: Which studies? MR. SIRRIDGE: Migrant. It's a type of BAYLEY REPORTING, INC. (202) 234-7787 (800) 368-8993 T11011-1644
Page 2: TI10111645
1 2 3 4 5 6 7 8 .9 i0 Ii 12 13 14 15 16 17 18 19 2O 21 22 23 24 25 epidemiologic study-- DR. GLANTZ : MR. SIRRIDGE : 458 Yes. Yes. -- where people move to different places and then their rates are compared against those of them who stayed in countries. There have been a number of studies which have measured Japan and places in the east with Hawaii and also with California, of all places. There has been a gradation of rates with a much higher risk for people who have moved here, suggesting the power and influence of traditional western risk factors. Is that true? DR. GLANTZ: I'm generally familiar with those studies from talking to colleagues about them and reading about them in the press. I wouldn't purport to be an expert on them. My understanding from this sort of general scientific knowledge is that the main changes that seem to account for those things are changes in diet, and again, no one is saying that diet isn't one of the risk factors for heart disease. It's important, I think, though, when you look at the ETS data, that they fact that we find reasonably consistent risks around the world, that, to me, is evidence that, again, the effects of ETS exist independent of those BAYLEY REPORTING, INC. (202) 234-7787 (800) 368-8993 T!1011-1645
Page 3: TI10111646
1 2 3 4 5 6 7 8 9 i0 Ii 12 13 14 15~ 16 17 18 19 2O 21 22 23 24 25 459 changes. MR. SIRRIDGE: Doctor, isn't it also true the there are problems comparing epidemiologic studies on heart disease from different countries? DR. GLANTZ: That's such a vague statement. MR. SIRRIDGE: All right. Would you agree with this statement: "The problem of comparability of epidemiologic data across different countries where racial ethnic groups is evident for cardiovascular diseases." DR. GLANTZ: Who said that? MR. SIRRIDGE: Anthony Padednick, Department of Community and Preventive Medicines, University of New York Stoneybrook. It's a chapter in a book he wrote in 1989, called "Racial and Ethnic Differences in Disease". DR. GLANTZ: Well, I mean, I'm not familiar with that~book and can't comment on it. I think that, as a general point, one needs to consider those differences when thinking about the studies, and I have, in my analysis of these studies. Another thing that I think speaks directly to this, and I'm sure Dr. Wells will address is, is when he did an analysis of the studies and separated the U.S. studies from the non-U.S, studies, you get quite comparable results, and also when you look at studies -- better studies -- which control for more of the potential confounding variables, you BAYLEY REPORTING, INC. (202) 234-7787 (800) 368-8993 TI1011-1646
Page 4: TI10111647
1 2 3 4 5 6 7 8 9 I0 ll 12 13 14 15 16 17 18 19 2O 21 22 23 24 25 460 get highe~ risks than when you don't. So the confounding, which we've heard so much about in the cross examination so far, if anything, is probably reducing the estimated risks. I think, while as a general statement, that quote you read perhaps is true. I think, in terms of ETS and heart disease it's not a problem. MR. SIRRIDGE: My point here, poctor, is that the ETS studies are from all over the world. They control for very few of the traditional major risk factors, and the relative risks seem too high to be plausible according to commentators of that evidence. DR. GLANTZ: I don't agree with that statement. I mean, I can speak to -- I mean, that's not an accurate statement. MR. SIRRIDGE: Are you familiar with the report by the Congressional Research Service with respect to that? DR. GLANTZ: Yes. MR. SIRRIDGE: I'm sure Mr. Repace gave you a copy of it, didn't he? DR. GLANTZ: No. I have a copy of it, but I got it from -- I don't even know who gave it to me -- MR. SIRRIDGE: But you've discussed this -- DR. GLANTZ: -- who it was -- MR. SIRRIDGE: -- you've discussed it with BAYLEY REPORTING, INC. (202) 234-7787 (800) 368-8993 Tl1011-1647
Page 5: TI10111648
1 2 3 4 5 6 7 8 9 I0 ll 12 13 14 15 '16 17 18 19 2O 21 22 23 24 25 461 Mr. Repac%? DR. GLANTZ: I don't think so, actually. I don't recall. I've discussed it with several people. I don't think I've talked to him about it. I'll be happy to -- I mean, it's a piece of trash. First of all, if I could quote from it -- JUDGE VITTONE: Dr. Glantz. DR. GLANTZ: Oh, okay. I'm sorry. MR. SIRRIDGE: You would like a question? JUDGE VITTONE: Yes. Ask it. DR. GLANTZ: Well, he's been making statements rather than asking questions. JUDGE VITTONE: Well, let me worry about that. DR. GLANTZ: Okay. JUDGE VITTONE: Okay. Now, do you have a question, Mr. Sirridge? MR. SIRRIDGE: I do, indeed. I'd like to read you a statement from the Congressional Research Service. DR. GLANTZ: Yes. MR. SIRRIDGE: You probably have it in front of your too. DR. GLANTZ: Yes, I've just gotten it. MR. SIRRIDGE: "The most likely explanation of these large risks" -- BAYLEY REPORTING, INC. (202) 234-7787 (800) 368-8993 T!1011-1648
Page 6: TI10111649
1 2 3 4 5 6 7 8 9 i0 ii 12 13 14 15 16 17 18 19 20 21 22 23 24 25 462 . DR. GLANTZ: Where -- where -- MR. SIRRIDGE: I'm sorry. From page 6 of the CRS, dated March 23rd, 1984. Your paper is cited, in fact, in the footnotes there. "The most likely explanation of these large risks from passive smoking, epidemiological studies for heart disease, is the absence of control for other factors. There are many important causes of heart disease (for example, diet, lack of exercise, lack of preventive health care) that may be engaged in by smokers. That is, there is much evidence that smokers tend to be less concerned about health risks in general. In general, studies do not and perhaps cannot control for many of these factors. If smokers' wives share in these behaviors, the relationships found in the epidemiologic studies are spurious." Did you consider that statement in reaching your conclusions for the 0SHApanel? DR. GLANTZ: Actually, I just realized that I don't have that document here. Do you have a copy I could read, before commenting on it? There were two reports, and I brought the one on economics rather than the one you're quoting from. MR. SIRRIDGE: DR. GLANTZ: MR. SIRRIDGE: I have one copy, is all I have. If I could just -- There's another one from September BAYLEY REPORTING, INC. (202) 234-7787 (800) 368-8993 TI 1011-1649
Page 7: TI10111650
1 2 3 4 5 6 7 8 9 I0 Ii 12 13 14 15 16 17 18 19 2O 21 22 23 24 25 13th. DR. GLANTZ: MR. SIRRIDGE: DR. GLANTZ: but I want to be accurate. MR. SIRRIDGE: Okay. DR. GLANTZ: I'm sorry. thing. question. it. 463 But I'll -- Certainly, I'll let you read that. Yes. I'm not trying to be difficult I brought the wrong JUDGE VITTONE: [Pause.] JUDGE VITTONE: That's okay. Let's hear the question first. DR. GLANTZ: Yes. I've forgotten. MR. SIRRIDGE: I've forgotten the precise JUDGE VITTONE: Yes. That's why I'd like to have MR. SIRRIDGE: Okay. JUDGE VITTONE: Okay. MR. SIRRIDGE: The question is, Doctor, this appears to be a statement by some analysts who have reviewed the evidence and have an understanding of the mechanisms and the risk factors associated with heart disease. True? DR. GLANTZ: No. And the reason for that, and the reason for -- apparently, there is yet a third Congressional Service document because I have seen the one BAYLEYREPORTING, INC. (202) 234-7787 (800) 368-8993 TI1011-1650
Page 8: TI10111651
5 6 7 8 9 I0 II 12 13 14 15 16 17 18 19 20 21 22 23 24 25 464 that you had, in which the authors point out that they are economists, not biomedical scientists, and really aren't competent to comment on the biological evidence. I found that report a remarkably irresponsible document. I mean, I would never write a paper for publication that said I'm not competent to make these statements, which, if I could have found the correct document, and I will provide to the record if need be. THe other thing, and the very, very fundamental flaw that exists in the CRS study is, it presumes a threshold for both lung cancer and heart disease, and there is no evidence accepted by the general scientific community that the threshold effect exists. ! think, first of all, the authors of that report, by their own admission, were not competent to write it.. Secondly, the assumptions they made are at great variance with established scientific view. Third, I checked about this and asked what kind of peer review did these documents get before they were released, and the answer was none. So I think that document is an appalling document. It's an embarrassing document. I had previously thought the Congressional Research Service did good work, and I hope that that's an exception to the rule. BAYLEYREPORTING, INC. (202) 234-7787 (800) 368-8993 T!1011-1651
Page 9: TI10111652
1 2 3 4 5 6 7 8 9 I0 Ii 12 13 15 16 17 18 19 2O 21 22 23 24 25 465 MR. SIRRIDGE: We' ll let others decide whether it's an exception, whether it's accurate. opinion. DR. GLANTZ : MR. SIRRIDGE : DR. GLANTZ : That's true. I'm entitled to my Absolutely. Dr. Glantz, you mentioned this morning that -- in fact, I was interested in your view that the relative risk for environmental tobacco smoke and heart disease could be i0. DR. GLANTZ: The data are -- if you look at, I think it was the Garland study done and not a terribly big one, from a statistical point of view, the relative risk could be anywhere in that 95 percent confidence interval with equal probability. I was not saying that I thought it was 10. I was just making a statistical statement based on that one study. If you look at the pooled estimate, the 95 percent confidence intervals are, in fact, quite narrow. They're about plus or minus .l, or probably even a little less than that, so I do not think the relative risk is MR. SIRRIDGE: Was the Garland ~tudy the one where they made the huge mathematical error? DR. GLANTZ: No. The Garland study, there was a typographical error in the paper, which Garlan subsequently published an erratumm on. There was not a mathematical BAYLEY REPORTING, INC. (202) 234-7787 (800) 368-8993 Tl1011-18~-52
Page 10: TI10111653
1 2 3 4 5 6 7 8 .9 i0 II 12 13 14 15 16 17 18 19 2O 21 22 23 24 25 466 error in their work. I actually, when people started claiming that, called Garland and asked him about it, and he sent me a copy of the erratum which had already been published. I believe they interpolated two numbers or printed the log instead of the actual numbers, but the analysis was correct. MR. SIRRIDGE: And the risk went from 14.7 down to 2.7? Is that your memory? DR. GLANTZ: The correct result -- the result in Garland's paper, as published with the erratum, had the correct number. Me did not change what he said the risk was. What they did was corrected a typo. The analysis that was done in that paper was done correctly. MR. SIRRIDGE: What do you think the risk is, if it's ~ot I0 -- you said you didn't think it was 10? DR. GLANTZ: I think it's around 1.3 -- 1.2 to 1.4, somewhere in there. MR. SIRRIDGE: Well, Doctor, haven't there been comments made by qualified analysts and scientists in the ETS area that even that risk is too high compared to the cardiovascular risk that's been reported for active smokers? DR. GLANTZ: Well, most of the criticism I'm aware of has come from the tobacco industry's consultants. BAYLEY REPORTING, INC. (202) 234-7787 (800) 368-8993 TI1011-1653

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size: